Arlington Capital Partners
 | |
| Private | |
| Industry | Private equity |
| Founded | 1999 |
| Founder | Matt Altman, Jeffrey H. Freed, Michael Lustbader, Robert Knibb, Peter Manos, Raymond W. Smith, Perry Steiner, Paul Stern |
| Headquarters | Washington, DC, U.S. |
| Products | Leveraged buyout, Growth capital |
| Total assets | Approximately $1.5 billion |
Number of employees | 20+ |
| Website | www.arlingtoncap.com |
Arlington Capital Partners is a Washington, DC based private equity firm focusing on leveraged buyout and recapitalization investments in middle market companies. Since inception in 1999, the firm has raised approximately $1.5 billion in investor commitments across three private equity funds.[1]
Arlington Capital Partners focuses on industries including: government contracting, federal and commercial IT and engineering services, aerospace/defense, healthcare services, education & training, and business services & outsourcing. Investments include Advanced Health, AdVenture Interactive, Apogen Technologies, Cambridge Major Laboratories, Compusearch Software Solutions, Consolidated Precision Products, The Daily Racing Form, NLX Corporation, Novetta Solutions, Virgo Holdings, and Zemax.[2][3]
References
- ↑ Arlington Capital Partners Press Release
- ↑ Arlington Capital Partners Investments
- ↑ "About us". Zemax.com. Retrieved September 10, 2015.
External links
- Arlington Capital (company website)